Literature DB >> 3023036

Insulin-induced hypoglycemia activates the release of adrenocorticotropin predominantly via central and propranolol insensitive mechanisms.

D Jezová, R Kvetnanský, K Kovács, Z Oprsalová, M Vigas, G B Makara.   

Abstract

The dynamic patterns of pituitary-adrenocortical and sympatho-adrenal hormone responses to insulin hypoglycemia as well as the relative importance of central vs. peripheral control of hypoglycemia-induced ACTH secretion were evaluated. In conscious rats bearing indwelling cannulae, the changes in hormone concentrations after insulin injection were dependent on the changes in blood glucose levels with respect to both time course and magnitude. ACTH, corticosterone, epinephrine, and norepinephrine levels were found to be maximal at 60 min after 2.5 IU kg-1 insulin injected ip, whereas earlier (20 min) but smaller increases were obtained in response to 0.5 IU kg-1 insulin injected iv. In rats 6-7 days after lesions of the medial basal hypothalamus (MBH), the rise of ACTH during insulin hypoglycemia was markedly inhibited and corticosterone levels were significantly reduced. Simultaneously, the hypoglycemia-induced increase in plasma epinephrine was unchanged and that in plasma norepinephrine was significantly enhanced in rats with the MBH destroyed. The beta-adrenoreceptor blocker propranolol did not inhibit ACTH and corticosterone responses to hypoglycemia in either sham-operated or MBH-lesioned animals. We conclude that the main factors triggering ACTH release during insulin-induced hypoglycemia are of central rather than peripheral origin. The high concentrations of circulating catecholamines occurring during insulin hypoglycemia are not responsible for pituitary-adrenocortical activation by direct, beta-adrenoreceptor mediated action at the pituitary level.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3023036     DOI: 10.1210/endo-120-1-409

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  8 in total

1.  Adrenomedullin and elements of orthostatic competence after 41 h of voluntary submersion in water as measured in four healthy males.

Authors:  Ingrid Loder; Andreas Rössler; Gert Wurzinger; Roman Duncko; Daniela Jezova; Helmut Hinghofer-Szalkay
Journal:  Eur J Appl Physiol       Date:  2006-01-14       Impact factor: 3.078

2.  Insulin-induced hypoglycemia stimulates corticotropin-releasing factor and arginine vasopressin secretion into hypophysial portal blood of conscious, unrestrained rams.

Authors:  A Caraty; M Grino; A Locatelli; V Guillaume; F Boudouresque; B Conte-Devolx; C Oliver
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

3.  The involvement of noradrenergic ascending pathways in the stress-induced activation of ACTH and corticosterone secretions is dependent on the nature of stressors.

Authors:  S Gaillet; J Lachuer; F Malaval; I Assenmacher; A Szafarczyk
Journal:  Exp Brain Res       Date:  1991       Impact factor: 1.972

4.  Plasma vasopressin, growth hormone and ACTH responses to static handgrip in healthy subjects.

Authors:  K Nazar; D Jezová; E Kowalik-Borówka
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1989

Review 5.  The role of intracellular messengers in adrenocorticotropin secretion in vitro.

Authors:  M S King; A J Baertschi
Journal:  Experientia       Date:  1990-01-15

6.  Alprazolam attenuates metabolic stress-induced neuroendocrine and behavioral effects in humans.

Authors:  A Breier; O R Davis; R W Buchanan
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

7.  Enhanced neuroendocrine response to insulin tolerance test performed under increased ambient temperature.

Authors:  D Jezová; R Kvetnanský; K Nazar; M Vigas
Journal:  J Endocrinol Invest       Date:  1998 Jul-Aug       Impact factor: 4.256

8.  Comparison of stress-induced changes in adults and pups: is aldosterone the main adrenocortical stress hormone during the perinatal period in rats?

Authors:  János Varga; Szilamér Ferenczi; Krisztina J Kovács; Alexandra Garafova; Daniela Jezova; Dóra Zelena
Journal:  PLoS One       Date:  2013-09-05       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.